Trial intelligence / Profile preview

Immunogenicity of Prevenar in patients with ataxia-telangiectasia

2005-004122-70Phase 4Completed

Sponsor
Great Ormond Street Hospital
Start
Sep 2005
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 4, randomised trial of pneumococcal 7-valent conjugate vaccine in pneumococcal disease and pneumonia (2 arms), sponsored by Great Ormond Street Hospital. Primary endpoint: Immunogenicity of the vaccine. Started Sep 2005; status: completed.

02

Drugs

pneumococcal 7-valent conjugate vaccine
03

Conditions

pneumococcal diseasepneumonia

Beyond the preview

Go deeper on 2005-004122-70.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-004122-70.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call